Christopher Rovaldi, SVP, Program Management and Operations at ACCELERON PHARMA INC (XLRN), sold 6,400 shares at $38.27 ($245K) on 2018-04-03, disclosed to the SEC on 2018-04-04.
Open-market sale of $245k XLRN by SVP, Program Management and Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.27 | 2,900 | $111K | 45.2% |
| 2 | $38.27 | 2,900 | $111K | 45.2% |
| 3 | $39.02 | 600 | $23K | 9.5% |
| Total | $38.34 avg | 6,400 | $245K | 100% |
| Filing → |
| XLRN | SELL | 2018-01-17 | $495K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $157K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $538K | — | Filing → |